Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Lassa virus matrix protein Z is a small, multifunctional protein essential for the life cycle of the Lassa virus, the causative agent of Lassa fever (UniProt P0C6G1). It plays a central role in viral assembly and budding by interacting with host cell ESCRT (endosomal sorting complex required for transport) machinery, specifically Tsg101 and Alix, through its late domain motifs (PubMed: 12767994). Additionally, the Z protein acts as a negative regulator of viral RNA synthesis by directly interacting with the viral L polymerase, thereby coordinating the transition from replication to assembly (PubMed: 20071563). It also contributes to immune evasion by inhibiting the RIG-I-mediated interferon response, which suppresses the host's innate antiviral defenses (PubMed: 20463082). Structurally, the protein contains a conserved RING finger domain that coordinates two zinc ions, which is critical for its structural integrity and various functions (PubMed: 15140961). Because the Z protein is indispensable for producing infectious progeny and modulating the host environment, it is a high-priority target for antiviral drug development. Current research focuses on identifying small molecules that can disrupt the RING domain or the protein's interactions with host factors to halt viral spread. While no drugs targeting the Z protein are currently FDA-approved, it remains a key focus for therapeutic intervention against Lassa fever.
Inhibition of viral budding by disrupting interactions with host ESCRT machinery or disruption of the RING finger domain to prevent viral assembly and replication regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lassa virus matrix protein Z (Z protein) (Z protein).